Lilly COVID-19 Antibody Has Role As Stopgap When Too Late To Vaccinate

Bamlanivimab Prevented Infections In Nursing Home Residents

 
• By Alaric DeArment

The company will seek emergency use authorization to prevent outbreaks in nursing homes. Regeneron is also positioning its antibody cocktail to prevent infections.

3D_Coronavirus
Eli Lilly said its antibody, bamlanivimab, is effective at preventing COVID-19 in long-term care facilities. • Source: Shutterstock

More from Business

More from Scrip